A sweeping analysis of more than 300 million lab tests from over a million women suggests that menopause does not creep up gradually — it strikes as an abrupt, body-wide “physiological cliff,” with dozens of health markers shifting sharply around the final period. For women navigating this transition, the findings offer something rare: a population-level map of when bodies tend to change most, and new evidence that hormone therapy may soften some of the sharpest shifts in bone and liver markers.
To be clear about what “cliff” means here: it describes a sharp pattern in average lab measurements across a huge population, not a sudden collapse in any one woman’s health. Most of the changes are gradual once you zoom out to a single lifetime — the surprise is how tightly they cluster around the final period when averaged across more than a million people.
Title: Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period
Authors: G. Pridham, Y. Hayut, N. Lavi-Shoseyov, et al.
Journal: Nature Medicine
DOI: 10.1038/s41591-026-04614-0
A Million Women, 300 Million Lab Tests
The study, led by systems biologist Uri Alon and colleagues at the Weizmann Institute of Science in Israel, set out to solve a surprisingly practical problem: almost no medical record states the exact date of a woman’s last period, so age alone has long stood in as a substitute — a poor one, since two 51-year-olds can be years apart in their reproductive timeline.
The team’s workaround, borrowed from a technique astronomers use to sharpen blurry telescope images, does not try to pinpoint any individual’s personal menopause date. Instead, it mathematically “deblurs” population-wide data — more than 300 million blood and urine tests from over one million women — to recover a clear, averaged timeline of how each lab measurement moves in the years before and after the final period, even though most records never say exactly when that period occurred.
They applied the method to two large, independent datasets: the US National Health and Nutrition Examination Survey (NHANES), a cross-sectional health study running from 1999 to 2022, and medical records from the Israeli health insurer Clalit, covering roughly 1.3 million women aged 30 to 70 between 2004 and 2024. Earlier menopause research mostly relied on small longitudinal cohorts that followed a few hundred women for a few years, which made it hard to separate ordinary aging from changes tied specifically to the hormonal transition. Lining up test results by time-to-final-period instead of calendar age, across two very different countries and health systems, let the team see a pattern that age-based comparisons alone had obscured.
The Cliff: Over Half the Markers Shift
Of 90 routine laboratory measurements tracked in the US dataset, 52 showed a statistically significant, abrupt shift clustered tightly around the final period — not a slow drift over years, but a change concentrated in a narrow window. The affected measures spanned sex hormones, bone metabolism, liver enzymes, kidney function, blood lipids, and general blood chemistry.
Crucially, men in the same dataset showed no comparable jump at an equivalent age; their values drifted gradually over decades. The authors take this as evidence that the cliff is a genuine signature of the menopausal transition itself, not simply a marker of growing older.
Researchers describe the pattern as a “step-like physiological cliff” that unfolds within roughly a year of the final period.
Hormones Begin Shifting Years Earlier
The cliff at the final period is not where the story starts. Hormonal change begins quietly more than a decade earlier: anti-Müllerian hormone (AMH), a marker of remaining egg supply, begins falling rapidly about 15 years before the final period; follicle-stimulating hormone (FSH) starts rising roughly 14 years before; and estradiol, the main form of estrogen, begins its decline about 12 years before.
By the time the final period itself arrives, these hormonal systems have already been shifting for a decade or more. The final period appears to mark an acceleration — a cascade into bone, liver, and cardiovascular systems — rather than the starting gun for the whole process.
Bone, Liver, and Heart Markers Shift
Across the 90 tests, jump sizes ranged from 0.1 to 1.4 standard deviations — a statistical measure of how far a test’s value moves, not a literal percentage change. The biggest jumps clustered in bone-related tests (including bone mineral density), liver tests, and lipid measures such as cholesterol, which the authors note are tissues with strong, well-documented sensitivity to estrogen. Separately, the same researchers found that the rate at which women are newly diagnosed with osteoporosis and cardiovascular disease accelerates right around the final period too — a pattern that, taken together with general background data showing roughly a quarter of women have osteoporosis by age 70, underscores why bone health is a major focus of menopause research, even though this study cannot say the lab-marker jump directly causes any individual case.
Not every change points downward: iron and red-blood-cell markers actually improve and anemia becomes less common — consistent with the simple fact that monthly menstrual bleeding has stopped. It is one of the few shifts in the “healthier” direction, and the researchers note it lines up with declining rates of anemia in the same population.
For an individual woman, the practical upshot is that the final period looks, in this data, like a rough marker for when several otherwise-unrelated health measures tend to shift together — not proof that any one woman’s bone scan, cholesterol panel, or liver test will change on cue, since individual biology varies widely around any population average.
Could Hormone Therapy Blunt the Fall?
Among women using menopausal hormone therapy, around half of the 80 tests compared showed significantly smaller shifts than non-users — especially bone, liver, and kidney markers — and in media interviews Alon described the therapy as appearing to “erase most of the bone cliff and much of the heart marker cliff.” But the comparison is observational, not a clinical trial: only a small share of women in the dataset used hormone therapy, so the difference could partly reflect who chooses or has access to treatment rather than the treatment itself. Hormone therapy also is not appropriate for everyone, including women with a history of certain cancers, blood clots, or untreated high blood pressure, and the authors say dedicated randomized trials are still needed to confirm any protective effect.
It’s a reminder that this kind of question — whether acting earlier can blunt age-related decline — keeps coming up across longevity research, including in an unrelated 12-year study that found a MIND-style diet was linked to years of slower brain aging. In both cases, the honest answer is that it will take dedicated, prospective trials to know for sure.
What Experts Say Is Still Unknown
Outside researchers welcomed the scale of the data while urging caution about the framing. JoAnn Manson of Harvard Medical School said the study “confirms the profound physiological changes” around the final period, while Rebecca Thurston of the University of Pittsburgh called hormone therapy “not a magic bullet” and emphasized healthy lifestyle habits and social connection alongside any medical treatment. Martha Hickey of the University of Melbourne cautioned that the “cliff” language could be “potentially alarming for women,” noting that the study does not show a dramatic physical or mental decline for most people.
The study itself is observational and cross-sectional, meaning it shows associations rather than proven cause and effect, and it cannot fully separate menopause-specific change from ordinary aging. Large gaps remain in the underlying data, and the hormone-therapy subgroup was small. What it does offer is a new way to study when menopause-linked changes emerge and how they connect to later health outcomes — the authors themselves frame it as extending the window for potential preventive care back by almost a decade, and as a strategy that could be applied to other hard-to-time biological transitions, such as puberty. Whether that translates into earlier screening or better-timed treatment for any individual woman is the next question, not something this study has already answered.
Sources: Nature Medicine, ScienceAlert, Newsweek
![[Science] Menopause Hits Like a Cliff, Not a Slope — 1-Million-Woman Study Finds](https://www.xsciens.com/wp-content/uploads/2026/10/featured.png)
![[Science] Climate Change Strengthened Hurricane Polo More Than El Niño, Study Finds](https://www.xsciens.com/wp-content/uploads/2026/10/hero_intro.png)
![[Science] What Is Cognitive Offloading? A Simple Guide to How It Works](https://www.xsciens.com/wp-content/uploads/2026/10/featured_image.png)
![[Science] Kids With Older Siblings Have Different Gut Bacteria — A Clue to Allergies?](https://www.xsciens.com/wp-content/uploads/2026/10/eyecatch.png)
![[Economy] The 2026 Economics Nobel — How Expectations Shape Recession Policy](https://www.xsciens.com/wp-content/uploads/2026/10/hero-1.png)
![[Science] Why Letting AI Help Can Erode Your Grit, Berkeley Study Finds](https://www.xsciens.com/wp-content/uploads/2026/10/hero.png)
![[Science] Earth’s Climate Indicators Hit Record Extremes in 2026 as Warming Speeds Up](https://www.xsciens.com/wp-content/uploads/2026/10/featured_climate_vitalsigns.png)

![[Science] A Retinal Chip Restores Reading Vision in Macular Degeneration — Gains Hold 3 Years Later](https://www.xsciens.com/wp-content/uploads/2026/10/intro_illustration-1.png)
![[Science] A ‘DNA Typewriter’ Maps How One Cell Becomes a Mouse — Clues to Birth Defects, Cancer](https://www.xsciens.com/wp-content/uploads/2026/10/hero_dna_typewriter.png)
